Health ❯Healthcare ❯Research ❯Clinical Trials

Alzheimer's Research

Leqembi Launches in Germany for Early Alzheimer’s Patients

Strict eligibility with extensive testing requirements shapes a rollout with reimbursement still unresolved.

Valacyclovir Shows No Benefit in Early Alzheimer’s Phase II Trial

Study Confirms Exercise Stabilizes Cognition in Older Adults at Risk for Alzheimer’s

Breakthrough Blood Test for Alzheimer’s Diagnoses Disease and Tracks Progression